• No results found

Clinical and laboratory features of mesenchymal stromal cells in pediatric stem cell transplantation Ball, L.M.

N/A
N/A
Protected

Academic year: 2021

Share "Clinical and laboratory features of mesenchymal stromal cells in pediatric stem cell transplantation Ball, L.M."

Copied!
11
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Ball, L.M.

Citation

Ball, L. M. (2010, March 4). Clinical and laboratory features of mesenchymal stromal cells in pediatric stem cell transplantation. Retrieved from

https://hdl.handle.net/1887/15035

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/15035

(2)

Clinical and Laboratory Features of

Mesenchymal Stromal Cells in Pediatric Stem

Cell Transplantation

(3)

COLOFON

Ball, Lynne Margaret 2010 ISBN: 978-90-8570-502-4

© L.M. Ball, Leiden, the Netherlands. All rights reserved. No part of this book may be reproduced or transmitted, in any form or by any means, without the written permission of the author.

Printed by Wöhrmann Print Service, Zutphen.

The printing of this thesis was financially supported by the Willem Alexander Kinder en Jeugd Centrum, Amgen BV, Gilead Sciences BV, Genzyme Nederland and Pfizer

(4)

3

3

Cover illustration:

Three Ages of Woman by Gustav Klimt, National Gallery of Modern Art, Rome, Italy.

By permission of Minestero per i Beni e le Attivitá Culturali.

" I have the gift of neither the spoken nor the written word, especially if I have to say something about myself or my work. Whoever wants to know something about me as an artist, the only notable thing, ought to look carefully at my pictures and try and see in them what I am and what I want to do."

- Gustav Klimt

(Baumgarten, 14 juli 1862 – Wenen, 6 februari 1918)

(5)
(6)

5

Clinical and Laboratory Features

of Mesenchymal Stromal Cells in Pediatric Stem Cell Transplantation

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof. mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 4 maart 2010

klokke 11.15 uur

door

Lynne Margaret Ball

geboren te Whiston, VK.,

in 1953

(7)

Promotie commissie

Promotores: Prof. Dr. R. M. Egeler Prof. Dr. W.E. Fibbe

Co-Promotor: Dr. M.J.D. van Tol

Overige Leden: Prof. F. Locatelli (University of Pavia, Italy) Prof. Dr. C.L. Mummery

Prof. Dr. R. Pieters (Erasmus University, Rotterdam)

The research described in this thesis was performed in the Departments of Pediatrics, Sub- Department Immunology, Haematology, Oncology, Bone Marrow

Transplantation and Autoimmune diseases (Prof dr. RM Egeler and Dr MJD van Tol) and Immuno-hematology and Blood Transfusion (Prof dr. W.E. Fibbe) of the Leiden University Medical Centre in collaboration with the Department of Pediatric Hematology/Oncology Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Italy, the Division of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska Institute, Huddinge University, Stockholm, Sweden and the Department of Bone Marrow Transplantation, Great Ormond Street Hospital, London, United Kingdom.

(8)

7

7

For my husband and daughter, Dick and Hannah

Aan mijn lieve Dick en dochter Hannah

(9)
(10)

9

Contents

Part 1 General introduction

Chapter 1 12

Published as

Potential role of mesenchymal stromal cells in paediatric hematopoietic stem cell transplantation.

BONE MARROW TRANSPLANTATION 2008; 42: S60–S66.

and

Immunotherapy in the context of hematopoietic stem cell transplantation; Focus on natural killer cells and mesenchymal stromal cells

PEDIATRIC CLINICS OF NORTH AMERICA. Coppes MJ, Mackall C , FryTJ (eds.) W B Saunders Company Philadelphia, USA. 2010; 57(1) in press.

Part 2 Alternative donors

Chapter 2 54

Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.

BONE MARROW TRANSPLANTATION 2005; 35: s35-38.

Chapter 3 66

Co-transplantation of ex vivo expanded mesenchymal stem cells accelerate lymphocyte recovery and may reduce the risk of graft failure in haplo-identical hematopoietic stem cell transplantation.

BLOOD, 2007; 110: 2765-2767

Chapter 4 76

Co-infusion of ex vivo expanded, parental mesenchymal stromal cells prevents life-threatening acute GvHD, but does not reduce the risk of graft failure in pediatric patients given allogeneic

umbilical cord blood transplantation.

IN PRESS BONE MARROW TRANSPLANTATION 2010

Chapter 5 100

Multiple infusions of haploidentical mesenchymal stromal cells are not immunogenic in children undergoing myeloablative stem cell transplantation.

SUBMITTED FOR PUBLICATION

(11)

Part 3 Acute Graft versus Host Disease

Chapter 6 108

Acute GvHD: pathogenesis and classification

BONE MARROW TRANSPLANTATION 2008; 41: S58–S64

Chapter 7 128

Use of bone marrow derived expanded mesenchymal stem cells in the treatment of steroid refractory acute GvHD.

LANCET 2008 371: 1579-1586

Chapter 8 148

Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft versus host disease in a child with juvenile

myelomonocytic leukemia.

LEUKEMIA 2008 22: 1256-1257.

Part 4 Viral infections

Chapter 9 156

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T cell responses

BLOOD. 2008; 1: 112: 532-541

Part 5

Chapter 10 186

Summary and General discussion

Part 6

Chapter 11 218

Future and potential uses of MSCs in pediatric medicine

Appendices

Nederlandse Samenvatting 256

Curriculum Vitae 264

Historical footnote 276

Abbreviations 280

Referenties

GERELATEERDE DOCUMENTEN

TAA-specific T cells are isolated using MHC I-Streptamers from healthy donors and are functionally analyzed to demonstrate whether clinically relevant antitumor

Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft versus host disease in a child with

(A) PBMC (1.5 × 10 5 per well) from normal donors were stimulated with irradiated (irr) allogeneic (allo) PBMC, irr autologous (autol) LCL, pp65-peptides or recombinant Ad5

However, associated problems of graft dysfunction, delayed immune reconstitution as well as steroid refractory acute graft versus host disease, reduce the effectiveness of these

Allogeneic 3 rd party bone marrow derived MSCs (Prochymal®) for the treatment of steroid refractory grade II-IV acute graft versus host disease following allogeneic hematopoietic

In Hoofdstuk 7 wordt de uitkomst beschreven van een Fase II onderzoek naar het gebruik van MSCs bij patiënten (zowel kinderen als volwassenen) met ernstige, graad II-IV,

Use of bone marrow derived expanded mesenchymal stem cells to augment hematopoietic cord blood stem cell transplantation.. Bone Marrow Transplant Accepted

Graft failure and delays in immune reconstitution reduce the overall survival of children undergoing haploidentical CD34 selected peripheral blood stem cell transplantation